CRISPR Therapeutics (CRSP) Balance Sheet Annual - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)

* (except for per share items) of USD
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2025-02-11 2024-02-21 2023-02-21 2022-02-15 2021-02-16 2020-02-12 2019-02-25 2018-03-08 2017-03-10 2015-12-31 2014-12-31
Total Current Assets 1,937 1,908 1,853 2,418 1,717 988 466 248 320 157 0.97
Cash and Short Term Investments 1,904 1,694 1,815 2,379 1,690 944 457 240 316 156 0.94
Cash & Equivalents 298 389 212 923 1,169 944 457 240 316 156 0.94
Short Term Investments 1,606 1,304 1,603 1,456 522 0.00 0.00 0.00 0.00 0.00 0.00
Receivables 25.0 200 0.00 0.30 0.14 0.10 0.09 2.63 3.16 0.34 0.00
Inventory 0.00 0.00 -11.2 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Assets 8.31 14.4 48.9 38.1 26.1 43.7 9.66 6.00 1.51 0.54 0.02
Total Assets 2,242 2,230 2,243 2,752 1,828 1,067 489 271 345 159 1.53
Total Non-Current Assets 305 321 390 334 111 79.2 22.6 23.0 24.8 2.58 0.56
Property, Plant and Equipment 278 306 321 312 93.0 72.8 18.5 18.9 21.0 1.33 0.00
Goodwill and Intangible Assets 0.00 0.02 0.07 0.12 0.18 0.24 0.29 0.34 0.40 0.45 0.51
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Intangible Assets 0.00 0.02 0.07 0.12 0.18 0.24 0.29 0.34 0.40 0.45 0.51
Long Term Investments 0.00 1.97 53.1 16.9 16.8 5.04 3.16 3.15 3.15 0.70 0.00
Deferred Tax Assets 0.00 0.00 0.00 -16.9 -16.8 -5.04 -3.16 -3.15 -3.15 -0.70 0.00
Other Long Term Assets 27.3 13.6 16.3 22.2 18.1 6.14 3.83 3.76 3.35 0.80 0.05
Total Current Liabilities 87.8 109 121 120 94.3 57.1 27.7 14.5 22.0 10.2 2.15
Accounts Payable 14.7 38.1 27.4 14.8 9.09 5.94 5.07 1.64 4.57 1.58 0.21
Notes Payable/Short Term Debt 17.3 43.6 31.7 24.3 22.7 17.0 0.00 0.00 0.00 0.00 0.00
Tax Payables 0.45 0.44 0.14 0.72 10.5 0.58 0.40 0.35 0.02 0.08 0.01
Deferred Revenue 3.84 4.11 12.3 1.01 2.34 0.96 57.8 56.9 77.6 0.00 0.00
Other Current Liabilities 51.5 22.5 49.5 79.0 49.6 32.6 -35.5 -44.4 -60.2 8.49 1.92
Total Liabilities 310 347 368 352 164 127 96.8 83.5 112 189 8.50
Total Non-Current Liabilities 222 238 246 233 69.5 70.2 69.1 69.0 90.1 178 6.36
Total Long Term Debt 206 223 228 213 50.1 44.0 0.00 0.00 0.00 -26.2 0.00
Deferred Tax Liabilities Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 64.5 0.00
Deferred Revenue Non-Current 0.00 14.0 12.3 12.3 11.8 11.8 57.8 56.9 77.6 75.1 0.00
Capital Lease Obligations 0.00 239 244 225 61.4 52.5 0.00 0.00 0.00 -64.5 0.00
Other Long Term Liabilities 15.8 -238 -238 -218 -53.8 -38.1 11.3 12.1 12.5 129 6.36
Total Equity 1,932 1,883 1,875 2,399 1,664 939 392 188 233 -29.1 -6.97
Non-Controlling Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 0.14
Total Stockholders' Equity 1,932 1,883 1,875 2,399 1,664 939 392 188 233 -29.1 -7.12
Retained Earnings -1,366 -1,000 -846 -196 -574 -225 -292 -125 -57.1 -33.9 -8.40
Accumulated Other Earnings 1.84 1.91 -15.6 -5.07 -0.08 0.01 -0.01 0.01 -0.03 -0.01 0.00
Common Stock 2.70 2.50 2.44 2.39 2.28 1.85 1.58 1.24 1.22 0.18 0.12
Preferred Stock 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 64.5 6.27
Additional Paid in Capital 3,293 2,878 2,735 2,598 2,236 1,162 682 312 289 -64.5 -6.27
Total Liabilities & Total Equity 2,242 2,230 2,243 2,752 1,828 1,067 489 271 345 159 1.53
Total Liabilities & Shareholders' Equity 2,242 2,230 2,243 2,752 1,828 1,067 489 271 345 159 1.53
Total Investments 1,606 1,306 1,657 1,456 522 5.04 3.16 3.15 3.15 0.70 0.00
Total Debt 224 239 244 225 61.4 52.5 0.00 0.00 0.00 38.3 0.00
Net Debt -74.6 -151 32.1 -698 -1,107 -891 -457 -240 -316 -118 -0.94
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us